Skip to content

Application value of whole-procedure optimization for catheter ablation of atrial fibrillation

Application value of whole-procedure optimization for catheter ablation of atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075595
Enrollment
Unknown
Registered
2023-09-08
Start date
2023-09-10
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

group1:pulmonary veins isolation plus superior vena cava isolation
group2:pulmonary veins isolation, superior vena cava isolation, ethanol Infusion of the vein of Marshall plus linear ablations of mitral isthmus, cavotricuspid isthmus and left atrium roofline

Sponsors

Department of Cardiology, He'nan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 to 80 years; 2.Radiofrequency catheter ablation was performed for the first time; 3.There are ECG which can be definitely diagnosed as atrial fibrillation, that is: P wave disappeared, replaced by F wave, frequency 350-600 times / min, QRS wave rhythm is absolutely irregular, RR interval is uneven, QRS wave shape is normal; 4.There were palpitation, chest tightness and other symptoms, or the application of antiarrhythmic drugs (AAD) was ineffective; 5.Sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with thrombosis in left atrium; 2.Left ventricular ejection fraction was less than 35%; 3.thyroid function was abnormal; 4.Previous history of AF radiofrequency ablation and CABG; 5.Severe valvular heart disease or after prosthetic valve surgery; 6. The diameter of left atrium was more than 65 mm or the volume was more than 200 ml; 7.The existence of surgical contraindications or other conditions not suitable for surgery; 8.The subjects are participating in other clinical trials that may affect this study.

Design outcomes

Primary

MeasureTime frame
Recurrence and ablation-related complications of atrial fibrillation;

Secondary

MeasureTime frame
The initial block rate of pulmonary veins isolation, superior vena cava isolation and additional ablation lines;

Countries

China

Contacts

Public ContactChu Yingjie

Department of Cardiology, He'nan Provincial People's Hospital

hnqbdsl@126.com+86 139 3719 9780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026